Large gap with delayed quotes
|
Official
12/27/2024 -
17:00:00
|
Bid
12/27/2024 -
16:12:26
|
Bid Volume |
Ask
12/27/2024 -
16:12:26
|
Ask Volume |
|---|---|---|---|---|
|
11.05
+0.20
(
+1.84% )
|
10.95
|
1,200 |
11.24
|
100 |
Analysis date: 24.12.2024
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 11.10.2024.
Interest
Weak
Weak
Weak interest since 22.11.2024.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 03.09.2024 at a price of 6.07.
Evaluation
Undervalued
Undervalued
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
Negative
Negative
The forty day Medium Term Technical Trend is negative since 22.11.2024. The confirmed Technical Reverse point (Tech Reverse + 1.75%) is
4wk Rel Perf
-6.16%
-6.16%
The four week relative underperformance versus SP500 is 6.16%.
Sensibility
Middle
Middle
Moderate, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.92%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 4.25%.
Mkt Cap in $bn
2.74
2.74
With a market capitalization between $2 & $8bn, BAUSCH HEALTH is considered a mid-cap stock.
G/PE Ratio
7.17
7.17
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
1.37
1.37
The estimated PE is for the year 2026.
LT Growth
9.79%
9.79%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
6
6
Over the last seven weeks, an average of 6 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
28
28
For 1% of index variation, the stock varies on average by 0.28%.
Correlation
0.07
0.07
Stock movements are totally independent of index variations.
Value at Risk
1.48
1.48
The value at risk is estimated at USD 1.48. The risk is therefore 19.69%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002